In July 2016, the FDA granted approval on the InPen, the first and only FDA-approved wireless-enabled insulin pen that calculates and recommends optimal dosing, tracks and records a one's doses and times, and shares dosing information with your health care provider through a mobile app. The Diabetes Dish spoke to The InPen's creator Sean Saint, CEO of Companion Medical, the pen's manufacturer, to learn about his inspiration for the pen, the pen's features and how it's impacted his own type 1 diabetes.